Previous 10 | Next 10 |
CANTON, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
CANTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, toda...
SAN FRANCISCO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now . Organogenesis Holdings Inc. (ORGO) Investigation: Organogenesis is a regenerative medicine comp...
San Francisco, California--(Newsfile Corp. - October 28, 2021) - Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/ORGO Contact An Attorney Now: ORGO@hbsslaw.com ...
CANTON, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Organogenesis Holdings, Inc. (NASDAQ: ORGO) for potential securities law violations. Investors who have lost money in their Organogenesis Holdings, Inc. investment should contact the firm to learn more about ...
SAN FRANCISCO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Organogenesis Holdings Inc. (NASDAQ: ORGO) investors with significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/ORGO Contact An Attorney Now: ORGO@hbsslaw.com ...
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our investi...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Organogenesis To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 15, 2021) - Faruqi & Faruqi, LLP, a leading national securitie...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Organogenesis To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 14, 2021) - Faruqi & Faruqi, LLP, a leading national securitie...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...